Monopar Therapeutics Inc. (MNPR)

NASDAQ: MNPR · Real-Time Price · USD

41.23

-0.73 (-1.74%)

At close: Apr 30, 2025, 3:59 PM

41.82

1.43%

After-hours: Apr 30, 2025, 04:56 PM EDT

Monopar Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-15.59B	-8.4M	-10.52M	-9.1M	-6.3M	-4.22M	-3.23M	-16.55M	-1.19M
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	1.14B	1.9M	1.64M	1.47M	1.32M	1.01M	529.33K	305.2K	n/a
Other Working Capital	2.98M	-20.41K	167.52K	-86.2K	-3.79K	-47.51K	-275.84K	-126.78K	298.00
Other Non-Cash Items	8.04B	n/a	162.96K	1.06M	-122.4K	767.64K	441.65K	13.5M	9.33K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	3.49M	-1.35M	1.65M	317.77K	443.81K	196.02K	-188.16K	120.58K	-9.04K
Operating Cash Flow	-6.4B	-7.86M	-7.23M	-7.32M	-4.66M	-3.02M	-2.89M	-2.63M	-1.19M
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-15.32B	-7.88M	-4.92M	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	985.73M	12.81M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	-4.92K	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-14.34B	4.93M	-4.92M	n/a	n/a	n/a	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	122.4K	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	59.23B	-46.97K	-76.46K	-45.77K	-115.57K	-874.81K	-206.27K	4.83M	n/a
Financial Cash Flow	59.29B	2.03M	32.87K	10.88M	8.18M	9.35M	-206.27K	9.54M	1.26M
Net Cash Flow	38.55B	-920.11K	-12.12M	3.57M	3.52M	6.32M	-2.89M	6.91M	67.87K
Free Cash Flow	-6.4B	-7.86M	-7.23M	-7.32M	-4.66M	-3.02M	-2.89M	-2.63M	-1.19M